ReviewJournal of clinical medicine2023

Current Role of SLGT2 Inhibitors in the Management of the Whole Spectrum of Heart Failure: Focus on Dapagliflozin.

Carlos Escobar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.